Biora Therapeutics, Inc. (BIOR)

USD 0.22

(0.0%)

Revenue Summary of Biora Therapeutics, Inc.

  • Biora Therapeutics, Inc.'s latest annual revenue in 2023 was 4000.00 USD , down -98.69% from previous year.
  • Biora Therapeutics, Inc.'s latest quarterly revenue in 2024 Q2 was 318 Thousand USD , down -41.33% from previous quarter.
  • Biora Therapeutics, Inc. reported a annual revenue of 305 Thousand USD in annual revenue 2022, down -75.54% from previous year.
  • Biora Therapeutics, Inc. reported a annual revenue of 1.24 Million USD in annual revenue 2021, down -98.32% from previous year.
  • Biora Therapeutics, Inc. reported a quarterly revenue of 542 Thousand USD for 2024 Q1, down -37.84% from previous quarter.
  • Biora Therapeutics, Inc. reported a quarterly revenue of 2000.00 USD for 2023 Q2, down 0.0% from previous quarter.

Annual Revenue Chart of Biora Therapeutics, Inc. (2023 - 2018)

Historical Annual Revenue of Biora Therapeutics, Inc. (2023 - 2018)

Year Revenue Revenue Growth
2023 4000.00 USD -98.69%
2022 305 Thousand USD -75.54%
2021 1.24 Million USD -98.32%
2020 74.31 Million USD -48.39%
2019 143.98 Million USD 12.51%
2018 127.97 Million USD 0.0%

Peer Revenue Comparison of Biora Therapeutics, Inc.

Name Revenue Revenue Difference
America Great Health 204.3 Thousand USD 98.042%
Ampio Pharmaceuticals, Inc. - USD -Infinity%
Aridis Pharmaceuticals, Inc. - USD -Infinity%
Bio-Path Holdings, Inc. - USD -Infinity%
Better Therapeutics, Inc. - USD -Infinity%
Calithera Biosciences, Inc. - USD -Infinity%
Comera Life Sciences Holdings, Inc. 633.1 Thousand USD 99.368%
Gene Biotherapeutics, Inc. - USD -Infinity%
eFFECTOR Therapeutics, Inc. - USD -Infinity%
Eloxx Pharmaceuticals, Inc. - USD -Infinity%
Evelo Biosciences, Inc. - USD -Infinity%
Evolutionary Genomics, Inc. - USD -Infinity%
Finch Therapeutics Group, Inc. 107 Thousand USD 96.262%
Galera Therapeutics, Inc. - USD -Infinity%
Innovation1 Biotech Inc. - USD -Infinity%
Kiromic BioPharma, Inc. - USD -Infinity%
Molecular Templates, Inc. 57.3 Million USD 99.993%
Navidea Biopharmaceuticals, Inc. 65.65 Thousand USD 93.907%
NexImmune, Inc. - USD -Infinity%
Orgenesis Inc. 530 Thousand USD 99.245%
Panbela Therapeutics, Inc. - USD -Infinity%
Point of Care Nano-Technology, Inc. - USD -Infinity%
PaxMedica, Inc. Common Stock - USD -Infinity%
Scopus BioPharma Inc. - USD -Infinity%
Sorrento Therapeutics, Inc. 62.83 Million USD 99.994%
Statera Biopharma, Inc. - USD -Infinity%
TRACON Pharmaceuticals, Inc. 12.04 Million USD 99.967%
Trevena, Inc. 3.12 Million USD 99.872%
Vaxxinity, Inc. - USD -Infinity%
Vaccinex, Inc. 570 Thousand USD 99.298%
Vicapsys Life Sciences, Inc. - USD -Infinity%
Viracta Therapeutics, Inc. - USD -Infinity%
ZIVO Bioscience, Inc. 27.65 Thousand USD 85.533%